Jonathan Allan - GENERAL COUNSEL & CORP SEC at Stoke Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
General Counsel & Corp Sec
Stock Symbol
STOK on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

Jonathan Allan - trading volume in the past year for Stoke Therapeutics, Inc.

Holdings reported by Jonathan Allan for Stoke Therapeutics, Inc.

Class Num Shares Value Price $ Report Date Ownership Underlying Class Underlying Amount
Restricted Stock Units 24,000 $379 K $15.78 Mar 27, 2024 Direct Common Stock
Common Stock 2,598 $39.1 K $15.04 May 20, 2024 Direct
Stock Option (Right to Buy) 25,801 May 20, 2024 Direct Common Stock

Transactions reported by Jonathan Allan for Stoke Therapeutics, Inc.

Sym Class Transaction % Value $ Price $ Shares Shares After Date Ownership